MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
8.07
-0.84
-9.43%
After Hours: 8.10 +0.03 +0.37% 19:57 10/05 EDT
OPEN
8.82
PREV CLOSE
8.91
HIGH
8.82
LOW
8.00
VOLUME
1.14M
TURNOVER
--
52 WEEK HIGH
24.67
52 WEEK LOW
8.00
MARKET CAP
138.41M
P/E (TTM)
-0.6246
1D
5D
1M
3M
1Y
5Y
1D
Companies Like Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Could Be Quite Risky
Simply Wall St · 21h ago
Weekly Report: what happened at TNXP last week (0928-1002)?
Weekly Report · 23h ago
Tonix Pharma Faces Generic TONMYA Patent Challenge
TipRanks · 3d ago
Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic TONMYA On Oct 1; Paragraph IV Certification Challenges Four TONMYA Patents Listed In FDA Orange Book; Co Intends To Enforce TONMYA Intellectual Property Rights
Benzinga · 3d ago
Tonix Pharma (TNXP) Receives a Buy from Alliance Global Partners
TipRanks · 09/28 13:15
Weekly Report: what happened at TNXP last week (0921-0925)?
Weekly Report · 09/28 09:10
Tonix Pharma expands TONMYA Medicare Part D coverage
TipRanks · 09/22 11:30
Analysts Are Bullish on Top Healthcare Stocks: ALX Oncology Holdings (ALXO), Tonix Pharma (TNXP)
TipRanks · 09/21 14:01
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.